Gufic BioSciences Ltd

Gufic BioScience | 509079

Market Closed

₹392.40

+₹5.46 (+1.41%)

As on 11/07/26, 1:21 AM

Market Cap3,935.09 CR

Current Price₹392.4

High / Low₹448 / 268

PE Ratio48.41

Book Value₹59.93

Dividend Yield0.03%

ROCE12.86%

ROE12.33%

Face Value₹2.00

Current Vol.1,32,576

Average Vol.---

ISININE742B01025

PB Ratio5.61

Debt to Equity0.59

Net Profit Margin8.5

Operating Margin17.04

Share Price Chart - Gufic BioSciences Ltd

+₹0.00 (+0.00%)6M

Stock Performance

₹386.95₹389

₹392.4

Previous CloseToday's Open

₹268₹448

₹392.4

52W Low52W High

₹389Today's Open

₹386.95Previous Close

1,32,576Volume

₹26852W Low

₹44852W High

Ratios

No data available

About Company

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network
The Company is ranked among the top 100 pharmaceutical companies in India
Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat
The Company was incorporated in July, 1984
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections
These products cover therapeutic areas, including antibiotics, antifungals, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs)
The Company made a reverse merger of itself with Central Finance
The promoters of GBL took over Central Finance at Rs 40-42 per share and then got GBL listed on BSE
Presently, the Company is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services

Ethics: Gufic BioSciences Ltd is flagged for

Adequate

---

Research Calls

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI58.71

SMA 20374.03

SMA 50338.35

SMA 100314.89

SMA 200326.75

SMA 10384.75

MACD_12_26_Days12.39

EMA10Day381.43

EMA20Day373.30

EMA50Day349.28

MACD_12_26_9_Days-1.69

EMA100Day333.56

EMA200Day333.80

Pivot Points

Volume Analysis

Delivery

Total Volume

Growth Rate

Revenue Growth1.63%

ROE12.29%

EBITDA Margin17.04%

All figures in ₹ Crores

Indicators	2025	2024
Revenue	819.81	806.67
Interest	24.52	16.79
Expenses	683.71	659.37
Financing Profit	139.73	149.48
Financing Margin %	17%	19%
Other Income	3.63	2.18
Depreciation	21.06	17.02
Profit before tax	94.14	115.67
Tax %	26%	26%
Net Profit	69.65	86.14
EPS in Rs	6.95	8.74

Show % Change

ShareHolding

📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.

Record Date

Corporate Action

Information

Announcement Day

29 Sept 2025

AGM

10 Sept 2025

22 Sept 2025

Final Dividend (₹0.1)

Recommendation of Final Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year 2024-25, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company.

30 May 2025

25 Sept 2024

AGM

04 Sept 2024

19 Sept 2024

Final Dividend (₹0.1)

Gufic BioSciences Ltd. Equity Rs.0.1000 per share(10%)Final Dividend Intimation for book closure and record date for the purpose of 40th Annual General Meeting and payment of final dividend for the financial year ended March 31, 2024. (As Per BSE Announcement dated on 31.08.2024)

29 May 2024

29 Sept 2023

AGM

01 Sept 2023

21 Sept 2023

Final Dividend (₹0.1)

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Monday, May 29, 2023, inter alia, recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year ended March 31, 2023, subject to the approval of the Shareholders at the ensuing Annual General Meeting With reference to the above captioned matter, we wish to inform you that the 39th Annual General Meeting ('AGM') of the Company is scheduled to be held on Friday, September 29, 2023 at 3:30 p.m. (IST) through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) to transact the Ordinary and Special Business as set out in the Notice convening the 39th AGM dated September 01, 2023. A copy of the Notice is attached herewith. Further, pursuant to the provision of Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Friday, September 22, 2023 to Friday, September 29, 2023 (both days inclusive) for the purpose of AGM and payment of final dividend for the financial year ended March 31, 2023 (As Per BSE Announcement dated on 06.09.2023)

29 May 2023

02 Sept 2022

AGM

11 Aug 2022

25 Aug 2022

Final Dividend (₹0.1)

In compliance with Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (including any statutory modification(s), amendment(s) and re-enactment(s) thereof), this is to inform that the Board of Directors of the Company at its Meeting held today i.e. Friday, May 20, 2022, inter alia, recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the Financial Year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing Annual General Meeting. Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the record date for the purpose of AGM and for payment of final dividend for the financial year ended March 31, 2022 is Thursday, August 25, 2022 and other details in this regard is attached herewith. (As Per BSE Announcement dated on 10.08.2022)

20 May 2022

20 Sept 2021

AGM

30 Aug 2021

14 Sept 2021

Final Dividend (₹0.1)

The Board of Directors of the Company at its Meeting held on June 04, 2021 inter alia considered and approved the following: Recommended Dividend @ 10% i.e. Re. 0.10 per equity share (Face Value of Re. 1/- each) for the financial year ended March 31, 2021, subject to the approval of the Shareholders at the ensuing Annual General Meeting.

04 Jun 2021

Peers

LTP(₹)	Market Cap(₹ Cr.)	P/E Ratio(Ratio)	P/B Ratio(Ratio)	Cash Earnings(Ratio)	Debt to Equity(Ratio)	Net Profit Ratio(%)
392	3,930	61	6	41	1	8.50%
1,935	4,64,331	37	6	30	0	19.78%
6,836	1,81,466	69	11	59	0	23.41%
4,903	1,65,952	76	20	50	1	11.09%
1,439	1,16,229	31	3	23	0	9.92%
1,151	1,14,763	21	4	17	0	19.86%
2,496	1,14,128	20	5	16	0	14.56%
2,525	1,04,275	52	6	36	0	14.39%
1,246	1,03,959	26	3	17	0	12.34%
1,565	90,875	26	2	17	0	10.98%

Showing 10 of 134 Results

#IndiaInvests

Trusted by 2.5 lac + Indians for their wealth-building needs

Invest in stocks with ease

Open your account in less than 10 mins*

By proceeding, you agree to all T&C *

Top Gainers

Top Losers

DIXONDixon Technologies (India) Ltd
₹13,421-56 (-0.42%)

Frequently Asked Questions

What is Share Price of Gufic BioSciences Ltd?

The current share price of Gufic BioSciences Ltd (Gufic BioScience) is ₹392.40. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Gufic BioSciences Ltd?

The Price-to-Earnings (P/E) ratio of Gufic BioSciences Ltd is 392.40. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Gufic BioSciences Ltd?

Gufic BioSciences Ltd has a 52-week high of ₹448.00 and a 52-week low of ₹268.00. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Gufic BioSciences Ltd?

Gufic BioSciences Ltd offers a dividend yield of 0.03%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Gufic BioSciences Ltd?

The Earnings Per Share (EPS) of Gufic BioSciences Ltd is ₹6.40. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Gufic BioSciences Ltd?

Gufic BioSciences Ltd has a Return on Equity (ROE) of 12.33%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

Ready to invest smarter?
Download the app today.

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

App Store

4.2

Discover our app's power in seconds. Play Video